Open AccessChemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first‐line treatment for advanced non‐small cell lung cancer
Author(s) -
Rizzo Alessandro
Publication year - 2022
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.14304
Subject(s) - medicine , pembrolizumab , chemoimmunotherapy , atezolizumab , oncology , lung cancer , clinical trial , nivolumab , immunotherapy , cancer